| 000 | 01502 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512102430.0 | ||
| 264 | 0 | _c19730202 | |
| 008 | 197302s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(72)90233-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKalisker, A | |
| 245 | 0 | 0 |
_aInhibition of the vasopressin-activated adenyl cyclase from renal medulla by prostaglandins. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cOct 1972 |
||
| 300 |
_a143-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalysis |
| 650 | 0 | 4 | _aAdenylyl Cyclase Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCarbon Isotopes |
| 650 | 0 | 4 | _aChromatography |
| 650 | 0 | 4 |
_aCyclic AMP _xanalysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Medulla _xenzymology |
| 650 | 0 | 4 |
_aOxytocin _xpharmacology |
| 650 | 0 | 4 |
_aParathyroid Hormone _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoenolpyruvate _xanalysis |
| 650 | 0 | 4 |
_aProstaglandins _xadministration & dosage |
| 650 | 0 | 4 |
_aPyruvate Kinase _xanalysis |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aTritium |
| 650 | 0 | 4 |
_aVasopressins _xadministration & dosage |
| 700 | 1 | _aDyer, D C | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 20 _gno. 1 _gp. 143-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(72)90233-6 _zAvailable from publisher's website |
| 999 |
_c4349272 _d4349272 |
||